C of A [GxP / QC / QA]

posted by Dr_Dan  – Germany, 2011-02-17 11:26 (5598 d 17:19 ago) – Posting: # 6640
Views: 8,990

Dear VM
usually you perform a clinical study in order to make a statement about the efficacy, the safety, the bioavailability etc. of the tested product. For this you definitely need to know the quality of the product. In your case you just need plasma samples in order to develop a bioanalytical method and there is no gain in knowledge about the drug. That's why I think that a CoA is not of that importance. Nevertheless it is always better to proof the assay content of the drug and if you use the data to describe the pharmacokinetics of the reference product in order to plan a BE study it would be better to have a CoA.
I hope this helps.
Kind regards
Dan

Kind regards and have a nice day
Dr_Dan

Complete thread:

UA Flag
Activity
 Admin contact
23,654 posts in 4,992 threads, 1,570 registered users;
137 visitors (0 registered, 137 guests [including 28 identified bots]).
Forum time: 05:46 CEST (Europe/Vienna)

Scientists often have a naïve faith that
if only they could discover enough facts about a problem,
these facts would somehow arrange themselves
in a compelling and true solution.    Theodosius Dobzhansky

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5